Company: SNY
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0001121404-25-000010
Chunk: 257

Company: Sanofi
Filing Date: 2025-02-13
Form: 20-F
Chunk 257
---
 Board decision of December 19, 2024, with effect from January 1, 2025. For the current composition of the Committee, refer to the Governance section of our corporate website: https://www.sanofi.com/en.. (b) Antoine Yver was appointed as Chair of the Scientific Committee by a Board decision of April 30, 2024. Work of the Committee in 2024 During 2024, the Committee’s work included the following key issues:

| l | Review of product portfolio.                                                                                                                                                 |
| l | Review of acquisition and alliance projects.                                                                                                                                 |
| l | Update on Vaccines.                                                                                                                                                          |
| l | Update on R&D transformation and roadmap.                                                                                                                                    |
| « | Update on R&D in France.                                                                                                                                                     |
| « | Update on Centers of Excellence.                                                                                                                                             |
| « | Update on fundamental research and early-stage development in immunology and inflammation including risk review, M&A/business developmentstrategy, and white space analysis. |

| lAnnual items | «Non-recurring items |

Attendance rates in 2024 The Committee met six times in 2024, with an overall attendance rate of 90%.

| 154 | SANOFIFORM 20-F2024 |

| PART I                                             |
| ITEM 6. Directors, Senior Management and Employees |

D. Employees Number of Employees (a) In 2024 , Sanofi e mployed 82,878 people worldwide, 3,210 fewer than in 2023 . The tables below give a breakdown of employees by geographical area and function as of December 31, 2024 , 2023 and 2022 . Employees by Geographical Area (a)

|                   | As of December 31, |        |        |        |        |        |
|                   |               2024 | %      |   2023 | %      |   2022 | %      |
| Europe            |             41,193 | 50%    | 42,115 | 49%    | 42,151 | 47%    |
| United States     |             12,898 | 16%    | 13,418 | 16%    | 13,761 | 15%    |
| Rest of the World |             28,787 | 35%    | 30,555 | 35%    | 33,912 | 38%    |
| Total             |             82,878 |